SEC Form 4 · accession 0001213900-16-018027
ORAMED PHARMACEUTICALS INC. · ORMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Xiaopeng Li
Director
Period of report
Nov 7, 2016
Accepted (ET)
Nov 7, 2016 · 2:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001176309
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 7, 2016 | A | 63,900 | $7.42 | A | 63,900 | D |
Table II — derivative securities
No Table II lines on this filing.